Evidence map›Paper›PMID 32817415›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

IL-12 p40 monomer is different from other IL-12 family members to selectively inhibit IL-12Rβ1 internalization and suppress EAE.

Susanta Mondal, Madhuchhanda Kundu, Malabendu Jana, Avik Roy, Suresh B Rangasamy, Khushbu K Modi, Jennillee Wallace, Yasmeen A Albalawi, Roumen Balabanov, Kalipada Pahan

RetractedOpen access · greenAbstract readRetracted Publication
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
2.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 51 citations in OpenAlex.

  1. CD4Nature medicine · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Dietary intake of whale oil-containing ω-3 long-chain polyunsaturated fatty acids attenuates choroidal neovascularization in mice.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  6. Article
  7. Article
  8. Build muscles and protect myelin.NeuroImmune pharmacology and therapeutics · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Susanta MondalDepartment of Neurological Sciences, Rush University Medical Center, Chicago, IL 60612.
Madhuchhanda KunduDepartment of Neurological Sciences, Rush University Medical Center, Chicago, IL 60612.
Malabendu JanaDepartment of Neurological Sciences, Rush University Medical Center, Chicago, IL 60612.
Avik RoyDepartment of Neurological Sciences, Rush University Medical Center, Chicago, IL 60612.
Suresh B RangasamyDepartment of Neurological Sciences, Rush University Medical Center, Chicago, IL 60612.
Khushbu K ModiDepartment of Neurological Sciences, Rush University Medical Center, Chicago, IL 60612.
Jennillee WallaceDepartment of Microbial Pathogens and Immunity, Rush University Medical Center, Chicago, IL 60612.
Yasmeen A AlbalawiDepartment of Microbial Pathogens and Immunity, Rush University Medical Center, Chicago, IL 60612.ORCID 0000-0001-8497-5240
Roumen BalabanovDepartment of Neurology, Northwestern University, Chicago, IL 60611.
Kalipada PahanDepartment of Neurological Sciences, Rush University Medical Center, Chicago, IL 60612; Kalipada_Pahan@rush.edu.ORCID 0000-0001-6048-9598
Rush University Medical Center · USNorthwestern University · US

Funding

Characterizing novel hippocampal drugs for Alzheimer's diseaseR01AG050431 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI PAHAN, KALIPADA · 2016 to 2020
$2.1M
Cinnamon, CNTF and EAER01AT006681 · NCCIH · RUSH UNIVERSITY MEDICAL CENTER · PI PAHAN, KALIPADA · 2011 to 2015
$1.8M
Identifying novel PPARß ligands from cerebellumR21NS097426 · NINDS · RUSH UNIVERSITY MEDICAL CENTER · PI PAHAN, KALIPADA · 2016 to 2017
$388k
Aspirin, PPAR and EAEI01BX002174 · VA · JESSE BROWN VA MEDICAL CENTER · PI PAHAN, KALIPADA · 2013 to 2016
–
BLR&D Research Career Scientist ApplicationIK6BX004982 · VA · JESSE BROWN VA MEDICAL CENTER · PI KALIPADA PAHAN · 2020 to 2026
–
BLRD VA I01 BX002174BLRD VA IK6 BX004982NCCIH NIH HHS R01 AT006681NIA NIH HHS R01 AG050431NINDS NIH HHS R21 NS097426
6 · The paper itself

Abstract

Multiple sclerosis (MS) is the most common human demyelinating disease of the central nervous system. The IL-12 family of cytokines has four members, which are IL-12 (p40:p35), IL-23 (p40:p19), the p40 monomer (p40), and the p40 homodimer (p40

Indexed as

AdultAnimalsCells, CulturedDisease Models, AnimalEncephalomyelitis, Autoimmune, ExperimentalFemaleHumansInterleukin-12Interleukin-12 Subunit p40Interleukin-23MaleMiceMice, Inbred C57BLMultiple SclerosisProtein BindingReceptors, Interleukin-12Interleukin-12Interleukin-12 Subunit p40Interleukin-23Receptors, Interleukin-12Recombinant ProteinsEAEIL-12 p40 monomerIL-12Rβ1multiple sclerosisrheumatoid arthritis

Identifiers

PMID32817415
PMCPMC7474649
OpenAlexW3055692844

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.